DrugPatentWatch Database Preview
Lupin Ltd Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for LUPIN LTD, and what generic alternatives to LUPIN LTD drugs are available?
LUPIN LTD has one hundred and forty-six approved drugs.
There is one US patent protecting LUPIN LTD drugs. There are seventeen tentative approvals on LUPIN LTD drugs.
There are two patent family members on LUPIN LTD drugs in two countries and three hundred and thirteen supplementary protection certificates in sixteen countries.
Summary for Lupin Ltd
| International Patents: | 2 |
| US Patents: | 1 |
| Tradenames: | 124 |
| Ingredients: | 108 |
| NDAs: | 146 |
| Drug Master File Entries: | 194 |
| Patent Litigation for Lupin Ltd: | See patent lawsuits for Lupin Ltd |
| PTAB Cases with Lupin Ltd as petitioner: | See PTAB cases with Lupin Ltd as petitioner |
Drugs and US Patents for Lupin Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin Ltd | BIMATOPROST | bimatoprost | SOLUTION/DROPS;OPHTHALMIC | 203991-001 | Feb 20, 2015 | AT | RX | No | Yes | Start Trial | Start Trial | ||||
| Lupin Ltd | AZITHROMYCIN | azithromycin | TABLET;ORAL | 065398-001 | May 15, 2015 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Lupin Ltd | ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE | abacavir sulfate; lamivudine; zidovudine | TABLET;ORAL | 202912-001 | Dec 5, 2013 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Lupin Ltd | NABUMETONE | nabumetone | TABLET;ORAL | 090445-001 | Jan 12, 2011 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Lupin Ltd | REPAGLINIDE AND METFORMIN HYDROCHLORIDE | metformin hydrochloride; repaglinide | TABLET;ORAL | 200624-001 | Jul 15, 2015 | DISCN | No | No | Start Trial | Start Trial | |||||
| Lupin Ltd | LEVETIRACETAM | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 091399-001 | Sep 12, 2011 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for LUPIN LTD drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | for Oral Suspension | 500 mg/5 mL | ➤ Subscribe | 2014-07-22 |
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
International Patents for Lupin Ltd Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2007119249 | Start Trial |
| Germany | 112007000920 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Lupin Ltd Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0503785 | CA 2011 00026 | Denmark | Start Trial | PRODUCT NAME: A COMBINATION OF OLMESARTAN MEDOXOMIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE; NAT. REG. NO/DATE: 46260-46269 (DK) 20110323; FIRST REG. NO/DATE: DE 79810.00.00 20101216 |
| 2236132 | C300714 | Netherlands | Start Trial | PRODUCT NAME: ZOLPIDEM EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NAT. REGISTRATION NO/DATE: RVG 108438 - 439 20130624; FIRST REGISTRATION: BE424286BE424295 2012180718 |
| 0720599 | CR 2014 00050 | Denmark | Start Trial | PRODUCT NAME: EZETIMIBE AND ATORVASTATIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, INCLUDING ATORVASTATIN AS ATORVASTATIN CALCIUM TRIHYDRATE; REG. NO/DATE: DE/H/3895-3898/001-004/DC 20140910 |
| 0933372 | 13/2008 | Austria | Start Trial | PRODUCT NAME: FOSAMPRENAVIR ALS FOSAMPRENAVIR-CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001 - EU/1/04/282/002 (MITTEILUNG VOM 14.07.2004) 20040713 |
| 1948158 | 122016000038 | Germany | Start Trial | PRODUCT NAME: SACUBITRIL/VALSARTAN, ALS SACUBITRIL VALSARTAN NATRIUM SALZKOMPLEX, D.H. TRINATRIUM-(3-((1 S,3R)-1-BIPHENYL-4-YLMETHYL-3-ETHOXYCARBONYL-1-BUTYLCARBAMOYL)PROPIONAT-(S)-3'-METHYL-2'-(PENTANOYL-(2"-(TETRAZOL-5-YLAT)BIPHENYL-4'-YLMETHYL)AMINO)BUTYRAT)-HEMIPENTAHYDRAT.; REGISTRATION NO/DATE: EU/1/15/1058 20151119 |
| 1915993 | C300625 | Netherlands | Start Trial | PRODUCT NAME: COMBINATIE BEVATTENDE ALISKIREN, OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, EN AMLODIPINE, OF EEN FARMACEUATISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/11/686/001-056 20110414 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
